Dynamic Changes of the Frequency of Classic and Inflammatory Monocytes Subsets and Natural Killer Cells in Chronic Hepatitis C Patients Treated by Direct-Acting Antiviral Agents

Table 1

Basic characteristics of subjects.

Index	CHC Patients	Healthy Controls
Number	15	10
Age (y)	48.06 ± 3.82	27.30 ± 3.40
Gender (M/f)	6/9	6/4
ALT (U/L, mean ± SE)	49.29 ± 7.47	NA
AST (U/L, mean ± SE)	52.78 ± 9.39	NA
HCV-RNA ( IU/mL)	6.02 ± 0.30	NA
HCV-RNA genotype	1b (42%)/6a (30%)/2a (28%)	NA
Treatment	Sofosbuvir + ledipasvir (8/15), sofosbuvir + daclatasvir (7/15)	NA
RVR/SVR	100%	NA

CHC patients: chronic hepatitis C patients; RVB: ribavirin; RVR: rapid virological response; SVR: sustained virological response.